{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:05:30Z","timestamp":1742702730714,"version":"3.40.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.livres.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:54:58Z","timestamp":1732078498000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-5579","authenticated-orcid":false,"given":"Peipei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dabiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishuo","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6839-7705","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-018-0041-6","article-title":"The hepatitis B epidemic and the urgent need for cure preparedness","volume":"15","author":"Lazarus","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.11.003_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.livres.2024.11.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1185492","article-title":"Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study","volume":"14","author":"Peng","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.livres.2024.11.003_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.31267","article-title":"Comparative effectiveness of entecavir versus tenofovir for preventing hepatocellular carcinoma in patients with chronic hepatitis B: a systematic review and meta-analysis","volume":"73","author":"Dave","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2024.11.003_bib5","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19-navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2024.11.003_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2024.11.003_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4110\/in.2015.15.4.191","article-title":"Immune-mediated liver injury in hepatitis B virus infection","volume":"15","author":"Oh","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.livres.2024.11.003_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/pathogens11070816","article-title":"COVID-19 as another trigger for HBV reactivation: clinical case and review of literature","volume":"11","author":"Sagnelli","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.livres.2024.11.003_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40121-022-00638-4","article-title":"Patients with COVID-19 and HBV coinfection are at risk of poor prognosis","volume":"11","author":"Yang","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.livres.2024.11.003_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3138\/canlivj-2020-0029","article-title":"HBV coinfection and in-hospital outcomes for COVID-19: a systematic review and meta-analysis","volume":"4","author":"Zhu","year":"2021","journal-title":"Can Liver J"},{"key":"10.1016\/j.livres.2024.11.003_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/liv.14774","article-title":"Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study","volume":"41","author":"Liu","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2024.11.003_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2391","article-title":"Update on the omicron sub-variants BA.4 and BA.5","volume":"33","author":"Tallei","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.livres.2024.11.003_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41392-022-01009-8","article-title":"Omicron: increased transmissibility and decreased pathogenicity","volume":"7","author":"B\u00e1lint","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.livres.2024.11.003_bib14","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S2666-5247(21)00266-4","article-title":"WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community","volume":"3","author":"Knezevic","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.livres.2024.11.003_bib15","doi-asserted-by":"crossref","first-page":"611.e9","DOI":"10.1016\/j.cmi.2021.11.002","article-title":"Female gender is associated with long COVID syndrome: a prospective cohort study","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.livres.2024.11.003_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12992-022-00804-w","article-title":"COVID-19, sex, and gender in China: a scoping review","volume":"18","author":"Feng","year":"2022","journal-title":"Global Health"},{"key":"10.1016\/j.livres.2024.11.003_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28695","article-title":"Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study","volume":"95","author":"Chen","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.livres.2024.11.003_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-021-0854-5","article-title":"Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study","volume":"16","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.livres.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.livres.2023.09.004","article-title":"Prolonged existence of SARS-CoV-2 RNAs in the extracellular vesicles of respiratory specimens from patients with negative reverse transcription-polymerase chain reaction","volume":"7","author":"Subudhi","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2024.11.003_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.livres.2023.07.001","article-title":"COVID-19 associated liver injury: an updated review on the mechanisms and management of risk groups","volume":"7","author":"Shi","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2024.11.003_bib21","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/jvh.13362","article-title":"Clinical characteristics in patients with SARS-CoV-2\/HBV co-infection","volume":"27","author":"Chen","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.livres.2024.11.003_bib22","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jmv.26201","article-title":"A\u00a0case series of COVID-19 patients with chronic hepatitis B virus infection","volume":"92","author":"Li","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.livres.2024.11.003_bib23","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2024.11.003_bib24","article-title":"COVID-19 induced hepatitis B virus reactivation: a novel case from the United Arab Emirates","volume":"12","author":"Aldhaleei","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.livres.2024.11.003_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12072-022-10306-x","article-title":"Management of hepatitis B virus reactivation due to treatment of COVID-19","volume":"16","author":"Yip","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2024.11.003_bib26","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3748\/wjg.v11.i14.2061","article-title":"Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV","volume":"11","author":"Ou","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2024.11.003_bib27","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in\u00a0vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"Delaney","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.livres.2024.11.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104857","article-title":"A\u00a0library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19","volume":"180","author":"Jockusch","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.livres.2024.11.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2024.11.003_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3748\/wjg.v27.i9.782","article-title":"Interaction between hepatitis B virus and SARS-CoV-2 infections","volume":"27","author":"Xiang","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2024.11.003_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and hepatitis B: current and future perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2024.11.003_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1104329","article-title":"Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon","volume":"13","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2024.11.003_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/apt.16786","article-title":"Risk of hepatocellular carcinoma in treatment-na\u00efve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2024.11.003_bib34","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0000000000003314","article-title":"Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV","volume":"36","author":"Li","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.livres.2024.11.003_bib35","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/QAD.0000000000003372","article-title":"Tenofovir disoproxil fumarate\/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection","volume":"36","author":"Del Amo","year":"2022","journal-title":"AIDS"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568424000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568424000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T05:41:28Z","timestamp":1742622088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568424000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2542568424000643"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2024.11.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"type":"print","value":"2542-5684"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}